Weight Loss Drug Zepbound Cuts Heart Failure Risk
Trial results show Eli Lilly’s weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company said on Thursday as it continues to build a case for the medication’s wider health… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]